Synergistic efficacy of PI3Kδ inhibitor with anti-PD-1 mAbs in immune-humanized PDX model of endocrine resistance hormone receptor-positive advanced breast cancer

PURPOSE: Endocrine resistance hormone receptor-positive (HR+) advanced breast cancer (ABC) is generally insensitive to immunecheckpoint inhibitors (ICIs). This study sought to determine whether PI3Kδ inhibitor could enhance the sensitivity of endocrine resistance HR + advanced BC to ICIs by reducing...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yingjue, Li, Yiwen, Yang, Yu, Deng, Yuwei, Ni, Xiangdong, Zhao, Bochen, Yan, Zhaoqi, He, Wen, Li, Yixin, Li, Shuhui, Liu, Linbo, Lu, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392091/
https://www.ncbi.nlm.nih.gov/pubmed/37533997
http://dx.doi.org/10.1016/j.heliyon.2023.e18498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392091/
https://www.ncbi.nlm.nih.gov/pubmed/37533997
http://dx.doi.org/10.1016/j.heliyon.2023.e18498

Ejemplares similares